These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity. Baker BR; Lourens GJ J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049 [No Abstract] [Full Text] [Related]
11. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride. Baker BR; Meyer RB J Med Chem; 1969 Jan; 12(1):108-11. PubMed ID: 5763004 [No Abstract] [Full Text] [Related]
12. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV. Baker BR; Lourens GJ J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172 [No Abstract] [Full Text] [Related]
13. Irreversible enzyme inhibitors. CLV. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[4-(omega-aminoalkoxy)-3-chlorophenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines bearing a terminal sulfonyl fluoride. Baker BR; Janson EE J Med Chem; 1969 Jul; 12(4):672-6. PubMed ID: 5793160 [No Abstract] [Full Text] [Related]